Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
UTHR
UTHR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UTHR News
United Therapeutics Corp Sees Surge in Options Trading Volume
1d ago
NASDAQ.COM
United Therapeutics Acquires Thymmune Therapeutics to Enhance Regenerative Medicine Pipeline
4d ago
NASDAQ.COM
United Therapeutics Acquires Thymmune for $140 Million
6d ago
NASDAQ.COM
United Therapeutics Acquires Thymmune for $140M
6d ago
seekingalpha
United Therapeutics Acquires Thymmune for Up to $300 Million
6d ago
NASDAQ.COM
United Therapeutics Acquires Thymmune Therapeutics for $140 Million
6d ago
Newsfilter
LungFX™ Receives FDA Approval for Lung Assessment
Jun 29 2026
Newsfilter
XMHQ Stock Performance Analysis and ETF Dynamics
Jun 22 2026
NASDAQ.COM
Space Pharma Market Thrives Amidst Mega-IPO Frenzy
Jun 09 2026
CNBC
Commercialization Prospects of Space Pharmaceuticals
Jun 09 2026
Newsfilter
United Therapeutics Corporation Ranked Top Stock by Renaissance Technologies
May 30 2026
Yahoo Finance
United Therapeutics' Tyvaso Shows Positive Results for Lung Fibrosis
May 19 2026
stocktwits
Tyvaso Shows Significant Efficacy in Phase 3 IPF Study
May 18 2026
Newsfilter
Renaissance Technologies Q1 2026 Performance Analysis
May 18 2026
seekingalpha
United Therapeutics' Drug Significantly Reduces Risk in Pulmonary Arterial Hypertension
May 18 2026
seekingalpha
Ralinepag Achieves Breakthrough Results in Pulmonary Arterial Hypertension Study
May 17 2026
Newsfilter
Show More News
